Algernon NeuroScience has appointed Dr. Sandor Nardai as the Principal Investigator for its upcoming randomized, double-blind, placebo-controlled Phase 2a DMT study of 40 stroke patients in Europe.

Algernon Pharmaceuticals (AGNPF) announced that its wholly owned subsidiary, Algernon NeuroScience, has appointed Validcare as the contract ...

Sarah Napthali lowers her voice over lunch when our conversation veers to the names of the drugs she used: LSD, MDMA, ...

Important training for athletes. Trump fires senior labor board official in ‘unprecedented and illegal’ move I Asked 4 Chefs ...

The DMT WKR1 winter shoes use an innovative design that provides another winter riding option. They are sleek and stylish, but I don't think they realise their full potential. Water can work its way ...

If the President’s first term was colored with protests and hashtags, his second has so far been characterized by a lack of ...

A few months before a Colorado state law went into effect this year allowing license facilitators to conduct therapeutic ...

But if you’re new to these gummies and would still like to try them, then take half a gummy ... and some products could contain potentially harmful research chemicals such as 4-AcO-DMT. It’s hard to ...

(RTTNews) - 4D Molecular Therapeutics (FDMT), a late-stage biotechnology company, on Wednesday announced that it will present initial interim results from the Phase 2b Population Extension cohort ...

The prosecutor told the court police then attended a Paralowie address on December 11 on information that DMT – a psychedelic drug – was being manufactured there. Kane Olsen was released on ...